Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethanol | HCID 702 | — |
| Reactant | Ethyl orthoformate | HCID 31214 | — |
| Reactant | HCID 508820 | HCID 508820 | — |
| Reactant | Sodium borohydride | HCID 4311764 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 18426271 | HCID 18426271 | — |
Reaction Steps
A triethyl orthoformate (6.5 mL) solution of 4-[N-(2-amino-5-bromobenzoyl)glycyl]aminomethyl-1-(4-chlorobenzyl)piperidine (Compd. No. 1042) (50 mg, 0.10 mmol) was stirred at 150° C. for 17 hours and concentrated to thereby provide a yellow solid. Sodium borohydride (7.6 mg, 0.2 mmol) was added to an ethanol (3 mL) solution of the yellow solid, and the mixture was stirred at room temperature for 14 hours. The resulting white precipitate was dissolved in dichloromethane, and the obtained solution was washed with a 1 M aqueous solution of NaOH (2 mL). The organic layer was separated, dried over K2CO3, filtered and concentrated, and the obtained crude product was purified by column chromatography (SiO2, 20% methanol/chloroform) to provide 4-[N-[5-bromo-2-(methylamino)benzoyl]glycyl]aminomethyl-1-(4-chlorobenzyl)piperidine (Compd. No. 1427) (40 mg, 80%). The purity was determined by RPLC/MS (100%). ESI/MS m/e 505 (M++H, C23H28BrClF6N4O2).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07390830B1 |
|---|
| Source dataset | uspto-grants-2008_06 |
|---|
| ORD ID | ord-96864e651fc94109a48b09f52cd68c64 |
|---|
| Source note | uspto-grants-2008_06 |
|---|